menu ☰
menu ˟

Equality and Human Rights Consultation - NICE TA - Trastuzumab Emtansine for Treating HER2 Positive Advanced Breast Cancer after Trastuzumab and a Taxane (Review of TA371)

Creator:

Department of Health

Subject Keywords: Breast Cancer
Set: Chronic Conditions
Conditions
Cancer
Catalogue: Guidance
NICE Guidance
Type: Guideline
Region: United Kingdom
Description:

NICE guidance is designed and developed for the NHS in England and is therefore not automatically applicable to Northern Ireland. On 1 July 2006 the Department established links with NICE whereby all technology appraisals and clinical guidelines published from that date are locally reviewed for applicability to Northern Ireland and, where appropriate, are endorsed for implementation in health and social care. THE LOCAL REVIEW DOES NOT REASSESS THE CLINICAL AND COST EVIDENCE USED BY NICE IN FORMING ITS ADVICE. This link has ensured that Northern Ireland has access to up-to-date, independent, professional, evidence-based guidance on the value of health care interventions.

Date:

19/06/2017

Rights: © Public
Suggested citation:

Department of Health. (2017) Equality and Human Rights Consultation - NICE TA - Trastuzumab Emtansine for Treating HER2 Positive Advanced Breast Cancer after Trastuzumab and a Taxane (Review of TA371) [Online]. Available from: http://www.thehealthwell.info/node/1097462 [Accessed: 19th October 2017].

  

View your saved citations and reading lists

Contributor:

Northern Ireland Cancer Network (NICaN)
 
Click here to view all the resources gathered from this organisation's website.